{Reference Type}: Journal Article
{Title}: National expert consensus on short-acting beta2-agonist overreliance in asthma care in Malaysia.
{Author}: Ban AY;Taher SW;Muneswarao J;Ho BK;Ahmad R;Pereirasamy L;Chong LY;Md Jamal S;Alaga A;Haja Mydin H;Chang LC;Md Isa NA;Mohd Zim MA;
{Journal}: J Asthma
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 1
暂无{DOI}: 10.1080/02770903.2024.2361780
{Abstract}: <B>UNASSIGNED: </B>Inappropriate use of short-acting beta2-agonists (SABA) in asthma has been associated with undesired outcomes. This national expert consensus was developed to increase awareness of SABA overuse and provide recommendations on the ways to eliminate SABA overprescription and overreliance in Malaysia.<BR><B>UNASSIGNED: </B>This expert consensus was developed by searching the PubMed database, using index terms to identify SABA overuse-related burden and recommendations made in asthma guidelines. Consensus recommendations were made via the Delphi method, involving a Malaysian expert committee comprising 13 healthcare professionals (five pulmonologists, four family medicine specialists, two emergency medicine physicians and two pharmacists).<BR><B>UNASSIGNED: </B>The articles reviewed include randomized controlled trials, systematic reviews, meta-analyses, observational studies, guidelines, and surveys, with abstracts in English and published up until June 2023. Relevant recommendations were also sourced from verified websites of medical organizations and societies.<BR><B>UNASSIGNED: </B>Eleven consensus statements were developed, each statement achieving a priori agreement level of at least 70%. The statements reflect SABA overreliance in asthma care, as well as recommendations to eliminate SABA overprescription and overreliance in Malaysia. Supporting evidence in the literature as well as expert committee discussions leading to the development of the finalized statements were elaborated.<BR><B>UNASSIGNED: </B>This national expert consensus discussed the burden of SABA overreliance and made specific recommendations to eliminate SABA overprescription and overreliance in the Malaysian context. This consensus document is anticipated to impart better awareness among Malaysian healthcare providers and contribute to the continuous improvement of asthma care in the country.